Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes.
about
Structural and Kinetic Analysis of Substrate Binding to the Sialyltransferase Cst-II from Campylobacter jejuniDevelopment of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strainsComparative genomic analysis of Campylobacter jejuni associated with Guillain-Barré and Miller Fisher syndromes: neuropathogenic and enteritis-associated isolates can share high levels of genomic similarity.Comparative genomic analysis of clinical strains of Campylobacter jejuni from South Africa.Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in BangladeshEpidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.Enteritis caused by Campylobacter jejuni followed by acute motor axonal neuropathy: a case report.Genetic divergence of Campylobacter fetus strains of mammal and reptile origins.Identification of Campylobacter heat-stable and heat-labile antigens by combining the Penner and Lior serotyping schemes.Sequence typing confirms that Campylobacter jejuni strains associated with Guillain-Barré and Miller-Fisher syndromes are of diverse genetic lineage, serotype, and flagella type.Amplified fragment length polymorphism analysis of Campylobacter jejuni strains isolated from chickens and from patients with gastroenteritis or Guillain-Barré or Miller Fisher syndrome.Survival of Campylobacter jejuni in waterborne protozoaCampylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope.Comparative genotyping of Campylobacter jejuni by amplified fragment length polymorphism, multilocus sequence typing, and short repeat sequencing: strain diversity, host range, and recombination.Identification of DNA sequence variation in Campylobacter jejuni strains associated with the Guillain-Barré syndrome by high-throughput AFLP analysis.Risk factors associated with Campylobacter jejuni infections in Curaçao, Netherlands Antilles.Evidence for acquisition of the lipooligosaccharide biosynthesis locus in Campylobacter jejuni GB11, a strain isolated from a patient with Guillain-Barré syndrome, by horizontal exchangeStructural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.Use of pcr-rflp of the fla a gene for detection and subtyping of Campylobacter jejuni strains Potentially related to Guillain-barré syndrome, isolated from humans and animals.The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patientsMolecular evidence for dissemination of unique Campylobacter jejuni clones in Curaçao, Netherlands Antilles.A DNase encoded by integrated element CJIE1 inhibits natural transformation of Campylobacter jejuni.Activation of human and chicken toll-like receptors by Campylobacter spp.Campylobacter jejuni HS:23 and Guillain-Barre syndrome, Bangladesh
P2860
Q27671666-3A5B1A28-952A-42DE-9A92-FA1A6ACCDD9FQ28361686-9457B890-D1B1-41ED-875C-369C7B7CF940Q33301762-F92E8AC5-0541-4332-99FF-BF349580832EQ33330309-B2109FC4-DCB1-4646-B91F-5A4D6720B893Q33507527-DE1745DC-5BCE-4B04-A595-37CBBD3A7FD4Q33592337-767D553E-5BB4-48D1-BB24-90A595C85054Q33780392-CAA178B2-4074-4DB7-A098-0CA5E21C1F59Q33884909-6941604F-43D2-4EAB-B05A-C1340B5F94DFQ33952240-20DBC687-A959-4430-A126-C56D09C26F6DQ33973485-47FC112E-A7E4-4E17-A2C8-78FFC02D2997Q33987636-CA24475F-9114-43A1-A7F6-6E96801E296AQ33995935-45E77005-DB35-4FF4-BAF8-9FD960CF9C8DQ34130499-12937A26-D267-44D8-AB34-00494DC31322Q34748753-19155539-2CCE-4249-81B4-B5BF46C2CCD1Q34805017-2E4B9390-8B65-4159-A19B-F0891AB2831CQ34956888-B16A6D23-05E0-4C50-A957-7EAE1E37DA37Q35549851-E59C91B5-A3F1-4065-BD2B-4CFAD6428448Q35689505-F7305B8C-7B69-4BBE-8BCF-40044A0622D6Q36986469-235FC78A-E844-4845-9370-7891B1EED419Q37159390-2271A96C-9701-4C19-B692-DB64EF697E55Q37625790-BE41DE27-A244-417A-81DB-2D4DD7D524E3Q39654221-5EC6B5D8-0969-4B44-85A5-EC11DC91C98AQ40404417-89CAE805-ECD7-4711-95E0-3DE2DF9A79E8Q41963718-296D0D5B-2F2D-4E68-BEB2-E062B9488E7CQ42076458-F7C302B7-BBB2-4241-A8B6-5D589B4E876EQ42862814-F3A44056-12AE-4B55-8371-B0E66A7B7A26
P2860
Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Molecular characterization of ...... é and Miller Fisher syndromes.
@ast
Molecular characterization of ...... é and Miller Fisher syndromes.
@en
type
label
Molecular characterization of ...... é and Miller Fisher syndromes.
@ast
Molecular characterization of ...... é and Miller Fisher syndromes.
@en
prefLabel
Molecular characterization of ...... é and Miller Fisher syndromes.
@ast
Molecular characterization of ...... é and Miller Fisher syndromes.
@en
P2093
P2860
P1476
Molecular characterization of ...... ré and Miller Fisher syndromes
@en
P2093
A van Belkum
B C Jacobs
D L Woodward
F G Rodgers
H A Verbrugh
J A Wagenaar
P2860
P304
P407
P577
2000-06-01T00:00:00Z